TriangleFecal Microbiota Transplantation (NCT06218602)
Fecal Microbiota Transplantation trial for Lymphoma (NCT06218602). This is a short film with English narration. The transcript is on this page, and the written brief is separate.
What the film says
Read the transcript
This trial is for adults with B-cell lymphoma scheduled for axicabtagene ciloleucel who received at least two days of specified antibiotics within 180 days before the infusion.
The idea: fecal microbiota transplantation aims to restore gut bacteria disrupted by antibiotics. Researchers compare chemotherapy and CAR T treatment with or without this treatment. They assess toxicity and cancer response. The transplant arm lists oral capsules and colonoscopy; the study team must confirm delivery details.
This phase 2 study plans 40 patients. Neeraj Saini leads at MD Anderson in Houston, the sole recruiting US site.
Public record; not medical advice.
Already in a trial?
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.